M

M

MOLES-MOREAU , Marie-Pierre

Last name: MOLES-MOREAU

First name: Marie-Pierre

May 2020 (v1)

Journal article

Metadata-only

Early F-FDG PET/CT response predicts survival in Relapsed/Refractory Hodgkin Lymphoma treated with Nivolumab

Chen, Aiping Mokrane, Fatima-Zohra Schwartz, Lawrence

Monoclonal antibodies (mAbs) against programmed cell death 1 (PD-1), such as nivolumab and pembrolizumab, are associated with high response rates in patients with relapsed or refractory classic Hodgkin lymphoma (HL). To date, no prognostic factor for overall survival (OS) has been established with these agents in HL. We examined whether the...

Uploaded on: December 4, 2022
June 2020 (v1)

Journal article

Metadata-only

Performance of CT Compared with F-FDG PET in Predicting the Efficacy of Nivolumab in Relapsed or Refractory Hodgkin Lymphoma

Mokrane, Fatima-Zohra Chen, Aiping Schwartz, Lawrence H

Background CT and fluorine 18 (F) fluorodeoxyglucose (FDG) PET/CT performances following immune therapy are not well known in patients with relapsed or refractory Hodgkin lymphoma (RRHL). Purpose To compare CT and PET/CT for prognostic value of early response evaluation following nivolumab therapy. Materials and Methods This retrospective study...

Uploaded on: December 4, 2022